#obviousness tag

The U.S. Court of Appeals for the Federal Circuit affirmed that Teva Pharmaceuticals did not prove the claims of Janssen Pharmaceuticals' patent for antipsychotic dosing regimens invalid for obviousness.

Law

Intellectual property law

fromPatently-O

2 months ago

Federal Circuit on Negative Limitations and Secondary Considerations

Federal Circuit maintains a strict approach to patent obviousness and secondary considerations.

Court underscores precise claim construction in patent cases.

#obviousness#obviousness

The Power of Unreviewability

CAFC Finds IPR Petitioner Did Not Rely on AAPA as Basis for Obviousness Grounds in Affirming PTAB Invalidation

Undetectable Amount of Magnification IS Magnification

Legacy of In re Rijckaert: Inherency's Limited Role in Obviousness Analysis

Don't Get Lazy, Timely Complete Your Arguments

CAFC Vacates PTAB's Finding that Meat Prep Patent Was Obvious

The Power of Unreviewability

CAFC Finds IPR Petitioner Did Not Rely on AAPA as Basis for Obviousness Grounds in Affirming PTAB Invalidation

Undetectable Amount of Magnification IS Magnification

Legacy of In re Rijckaert: Inherency's Limited Role in Obviousness Analysis

Don't Get Lazy, Timely Complete Your Arguments

CAFC Vacates PTAB's Finding that Meat Prep Patent Was Obvious

CAFC Upholds Win for Janssen on Patent for Antipsychotic Med Dosing Regimen

Federal Circuit on Negative Limitations and Secondary Considerations

#obviousness
#obviousness